This study evaluated the health-economic consequences of use of intravenous paricalcitol (Zemplar ®), oral calcitriol or oral and intravenous alfacalcidol for the treatment of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback